0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Allergen IgE Antibody Testing Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: November 2025
|
Report Code: QYRE-Auto-1X17197
Home | Market Reports | Health| Medical Facilities & Services| Medical Procedures
Global Allergen IgE Antibody Testing Market Research Report 2024
BUY CHAPTERS

Global Allergen IgE Antibody Testing Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-1X17197
Report
November 2025
Pages:152
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Allergen IgE Antibody Testing Market

The global Allergen IgE Antibody Testing market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Allergen IgE antibody detection is a method used to detect the concentration of IgE antibodies caused by specific allergens (such as pollen, dust mites, pet dander, food, etc.) in human blood. IgE antibodies are a reaction produced by the human immune system to allergens. Their presence indicates that the human body may be allergic to certain substances. This test can help doctors diagnose allergic diseases, such as allergic rhinitis, asthma, hives, etc., and determine which allergens a patient is reacting to.
From a downstream perspective, Aldult accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Allergen IgE Antibody Testing leading manufacturers including Oumeng, BioMerieux, Phadia, Mediwiss, Danaher, Omega Diagnostics Group, Biomerica, Stallergenes Greer, Siemens Healthineers, Quest Diagnostics, etc., dominate supply; the top five capture approximately % of global revenue, with Oumeng leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Allergen IgE Antibody Testing market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Allergen IgE Antibody Testing Market Report

Report Metric Details
Report Name Allergen IgE Antibody Testing Market
Segment by Type
  • Skin Prick Testing
  • Serum-Specific IE Testing
  • Patch Testing
  • In Vitro Allergen Testing
Segment by Application
  • Aldult
  • Child
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Oumeng, BioMerieux, Phadia, Mediwiss, Danaher, Omega Diagnostics Group, Biomerica, Stallergenes Greer, Siemens Healthineers, Quest Diagnostics, Lincoln Diagnostics, HOB Biotech, Beijing Macro Union Pharmaceutical, Hangzhou Zheda Dixun Biological
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Allergen IgE Antibody Testing study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
  • Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 15: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Allergen IgE Antibody Testing Market report?

Ans: The main players in the Allergen IgE Antibody Testing Market are Oumeng, BioMerieux, Phadia, Mediwiss, Danaher, Omega Diagnostics Group, Biomerica, Stallergenes Greer, Siemens Healthineers, Quest Diagnostics, Lincoln Diagnostics, HOB Biotech, Beijing Macro Union Pharmaceutical, Hangzhou Zheda Dixun Biological

What are the Application segmentation covered in the Allergen IgE Antibody Testing Market report?

Ans: The Applications covered in the Allergen IgE Antibody Testing Market report are Aldult, Child

What are the Type segmentation covered in the Allergen IgE Antibody Testing Market report?

Ans: The Types covered in the Allergen IgE Antibody Testing Market report are Skin Prick Testing, Serum-Specific IE Testing, Patch Testing, In Vitro Allergen Testing

1 Study Coverage
1.1 Introduction to Allergen IgE Antibody Testing: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Allergen IgE Antibody Testing Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Skin Prick Testing
1.2.3 Serum-Specific IE Testing
1.2.4 Patch Testing
1.2.5 In Vitro Allergen Testing
1.3 Market Segmentation by Application
1.3.1 Global Allergen IgE Antibody Testing Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Aldult
1.3.3 Child
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Allergen IgE Antibody Testing Revenue Estimates and Forecasts 2020-2031
2.2 Global Allergen IgE Antibody Testing Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Allergen IgE Antibody Testing Sales Estimates and Forecasts 2020-2031
2.4 Global Allergen IgE Antibody Testing Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Allergen IgE Antibody Testing Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Allergen IgE Antibody Testing Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Skin Prick Testing Market Size by Manufacturers
3.5.2 Serum-Specific IE Testing Market Size by Manufacturers
3.5.3 Patch Testing Market Size by Manufacturers
3.5.4 In Vitro Allergen Testing Market Size by Manufacturers
3.6 Global Allergen IgE Antibody Testing Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Allergen IgE Antibody Testing Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Allergen IgE Antibody Testing Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Allergen IgE Antibody Testing Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Allergen IgE Antibody Testing Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Allergen IgE Antibody Testing Sales and Revenue by Type (2020-2031)
6.4 North America Allergen IgE Antibody Testing Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Allergen IgE Antibody Testing Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Allergen IgE Antibody Testing Sales and Revenue by Type (2020-2031)
7.4 Europe Allergen IgE Antibody Testing Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Allergen IgE Antibody Testing Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Allergen IgE Antibody Testing Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Allergen IgE Antibody Testing Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Allergen IgE Antibody Testing Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Allergen IgE Antibody Testing Sales and Revenue by Type (2020-2031)
9.4 Central and South America Allergen IgE Antibody Testing Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Allergen IgE Antibody Testing Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Allergen IgE Antibody Testing Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Allergen IgE Antibody Testing Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Allergen IgE Antibody Testing Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Oumeng
11.1.1 Oumeng Corporation Information
11.1.2 Oumeng Business Overview
11.1.3 Oumeng Allergen IgE Antibody Testing Product Models, Descriptions and Specifications
11.1.4 Oumeng Allergen IgE Antibody Testing Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Oumeng Allergen IgE Antibody Testing Sales by Product in 2024
11.1.6 Oumeng Allergen IgE Antibody Testing Sales by Application in 2024
11.1.7 Oumeng Allergen IgE Antibody Testing Sales by Geographic Area in 2024
11.1.8 Oumeng Allergen IgE Antibody Testing SWOT Analysis
11.1.9 Oumeng Recent Developments
11.2 BioMerieux
11.2.1 BioMerieux Corporation Information
11.2.2 BioMerieux Business Overview
11.2.3 BioMerieux Allergen IgE Antibody Testing Product Models, Descriptions and Specifications
11.2.4 BioMerieux Allergen IgE Antibody Testing Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 BioMerieux Allergen IgE Antibody Testing Sales by Product in 2024
11.2.6 BioMerieux Allergen IgE Antibody Testing Sales by Application in 2024
11.2.7 BioMerieux Allergen IgE Antibody Testing Sales by Geographic Area in 2024
11.2.8 BioMerieux Allergen IgE Antibody Testing SWOT Analysis
11.2.9 BioMerieux Recent Developments
11.3 Phadia
11.3.1 Phadia Corporation Information
11.3.2 Phadia Business Overview
11.3.3 Phadia Allergen IgE Antibody Testing Product Models, Descriptions and Specifications
11.3.4 Phadia Allergen IgE Antibody Testing Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Phadia Allergen IgE Antibody Testing Sales by Product in 2024
11.3.6 Phadia Allergen IgE Antibody Testing Sales by Application in 2024
11.3.7 Phadia Allergen IgE Antibody Testing Sales by Geographic Area in 2024
11.3.8 Phadia Allergen IgE Antibody Testing SWOT Analysis
11.3.9 Phadia Recent Developments
11.4 Mediwiss
11.4.1 Mediwiss Corporation Information
11.4.2 Mediwiss Business Overview
11.4.3 Mediwiss Allergen IgE Antibody Testing Product Models, Descriptions and Specifications
11.4.4 Mediwiss Allergen IgE Antibody Testing Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Mediwiss Allergen IgE Antibody Testing Sales by Product in 2024
11.4.6 Mediwiss Allergen IgE Antibody Testing Sales by Application in 2024
11.4.7 Mediwiss Allergen IgE Antibody Testing Sales by Geographic Area in 2024
11.4.8 Mediwiss Allergen IgE Antibody Testing SWOT Analysis
11.4.9 Mediwiss Recent Developments
11.5 Danaher
11.5.1 Danaher Corporation Information
11.5.2 Danaher Business Overview
11.5.3 Danaher Allergen IgE Antibody Testing Product Models, Descriptions and Specifications
11.5.4 Danaher Allergen IgE Antibody Testing Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Danaher Allergen IgE Antibody Testing Sales by Product in 2024
11.5.6 Danaher Allergen IgE Antibody Testing Sales by Application in 2024
11.5.7 Danaher Allergen IgE Antibody Testing Sales by Geographic Area in 2024
11.5.8 Danaher Allergen IgE Antibody Testing SWOT Analysis
11.5.9 Danaher Recent Developments
11.6 Omega Diagnostics Group
11.6.1 Omega Diagnostics Group Corporation Information
11.6.2 Omega Diagnostics Group Business Overview
11.6.3 Omega Diagnostics Group Allergen IgE Antibody Testing Product Models, Descriptions and Specifications
11.6.4 Omega Diagnostics Group Allergen IgE Antibody Testing Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Omega Diagnostics Group Recent Developments
11.7 Biomerica
11.7.1 Biomerica Corporation Information
11.7.2 Biomerica Business Overview
11.7.3 Biomerica Allergen IgE Antibody Testing Product Models, Descriptions and Specifications
11.7.4 Biomerica Allergen IgE Antibody Testing Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Biomerica Recent Developments
11.8 Stallergenes Greer
11.8.1 Stallergenes Greer Corporation Information
11.8.2 Stallergenes Greer Business Overview
11.8.3 Stallergenes Greer Allergen IgE Antibody Testing Product Models, Descriptions and Specifications
11.8.4 Stallergenes Greer Allergen IgE Antibody Testing Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 Stallergenes Greer Recent Developments
11.9 Siemens Healthineers
11.9.1 Siemens Healthineers Corporation Information
11.9.2 Siemens Healthineers Business Overview
11.9.3 Siemens Healthineers Allergen IgE Antibody Testing Product Models, Descriptions and Specifications
11.9.4 Siemens Healthineers Allergen IgE Antibody Testing Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 Siemens Healthineers Recent Developments
11.10 Quest Diagnostics
11.10.1 Quest Diagnostics Corporation Information
11.10.2 Quest Diagnostics Business Overview
11.10.3 Quest Diagnostics Allergen IgE Antibody Testing Product Models, Descriptions and Specifications
11.10.4 Quest Diagnostics Allergen IgE Antibody Testing Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 Quest Diagnostics Recent Developments
11.11 Lincoln Diagnostics
11.11.1 Lincoln Diagnostics Corporation Information
11.11.2 Lincoln Diagnostics Business Overview
11.11.3 Lincoln Diagnostics Allergen IgE Antibody Testing Product Models, Descriptions and Specifications
11.11.4 Lincoln Diagnostics Allergen IgE Antibody Testing Sales, Price, Revenue and Gross Margin (2020-2025)
11.11.5 Lincoln Diagnostics Recent Developments
11.12 HOB Biotech
11.12.1 HOB Biotech Corporation Information
11.12.2 HOB Biotech Business Overview
11.12.3 HOB Biotech Allergen IgE Antibody Testing Product Models, Descriptions and Specifications
11.12.4 HOB Biotech Allergen IgE Antibody Testing Sales, Price, Revenue and Gross Margin (2020-2025)
11.12.5 HOB Biotech Recent Developments
11.13 Beijing Macro Union Pharmaceutical
11.13.1 Beijing Macro Union Pharmaceutical Corporation Information
11.13.2 Beijing Macro Union Pharmaceutical Business Overview
11.13.3 Beijing Macro Union Pharmaceutical Allergen IgE Antibody Testing Product Models, Descriptions and Specifications
11.13.4 Beijing Macro Union Pharmaceutical Allergen IgE Antibody Testing Sales, Price, Revenue and Gross Margin (2020-2025)
11.13.5 Beijing Macro Union Pharmaceutical Recent Developments
11.14 Hangzhou Zheda Dixun Biological
11.14.1 Hangzhou Zheda Dixun Biological Corporation Information
11.14.2 Hangzhou Zheda Dixun Biological Business Overview
11.14.3 Hangzhou Zheda Dixun Biological Allergen IgE Antibody Testing Product Models, Descriptions and Specifications
11.14.4 Hangzhou Zheda Dixun Biological Allergen IgE Antibody Testing Sales, Price, Revenue and Gross Margin (2020-2025)
11.14.5 Hangzhou Zheda Dixun Biological Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Allergen IgE Antibody Testing Industry Chain
12.2 Allergen IgE Antibody Testing Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Allergen IgE Antibody Testing Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Allergen IgE Antibody Testing Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Allergen IgE Antibody Testing Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Allergen IgE Antibody Testing Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
List of Tables
 Table 1. Global Allergen IgE Antibody Testing Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Allergen IgE Antibody Testing Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Allergen IgE Antibody Testing Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Allergen IgE Antibody Testing Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Allergen IgE Antibody Testing Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Global Allergen IgE Antibody Testing Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
 Table 7. Global Allergen IgE Antibody Testing Sales by Region (2020-2025) & (K Units)
 Table 8. Global Allergen IgE Antibody Testing Sales by Region (2026-2031) & (K Units)
 Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 10. Global Allergen IgE Antibody Testing Sales by Manufacturers (2020-2025) & (K Units)
 Table 11. Global Allergen IgE Antibody Testing Sales Share by Manufacturers (2020-2025)
 Table 12. Global Allergen IgE Antibody Testing Revenue by Manufacturers (2020-2025) & (US$ Million)
 Table 13. Global Allergen IgE Antibody Testing Revenue Market Share by Manufacturers (2020-2025)
 Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 15. Global Allergen IgE Antibody Testing by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Allergen IgE Antibody Testing as of 2024)
 Table 16. Global Allergen IgE Antibody Testing Average Gross Margin (%) by Manufacturer (2020 VS 2024)
 Table 17. Global Allergen IgE Antibody Testing Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
 Table 18. Key Manufacturers Allergen IgE Antibody Testing Manufacturing Base and Headquarters
 Table 19. Global Allergen IgE Antibody Testing Market Concentration Ratio (CR5 and HHI)
 Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 22. Global Allergen IgE Antibody Testing Sales by Type (2020-2025) & (K Units)
 Table 23. Global Allergen IgE Antibody Testing Sales by Type (2026-2031) & (K Units)
 Table 24. Global Allergen IgE Antibody Testing Revenue by Type (2020-2025) & (US$ Million)
 Table 25. Global Allergen IgE Antibody Testing Revenue by Type (2026-2031) & (US$ Million)
 Table 26. Global Allergen IgE Antibody Testing ASP by Type (2020-2031) & (US$/Unit)
 Table 27. Technical Specifications by Key Product Type
 Table 28. Global Allergen IgE Antibody Testing Sales by Application (2020-2025) & (K Units)
 Table 29. Global Allergen IgE Antibody Testing Sales by Application (2026-2031) & (K Units)
 Table 30. Allergen IgE Antibody Testing High-Growth Sectors Demand CAGR (2024-2031)
 Table 31. Global Allergen IgE Antibody Testing Revenue by Application (2020-2025) & (US$ Million)
 Table 32. Global Allergen IgE Antibody Testing Revenue by Application (2026-2031) & (US$ Million)
 Table 33. Global Allergen IgE Antibody Testing ASP by Application (2020-2031) & (US$/Unit)
 Table 34. Top Customers by Region
 Table 35. Top Customers by Application
 Table 36. North America Allergen IgE Antibody Testing Growth Accelerators and Market Barriers
 Table 37. North America Allergen IgE Antibody Testing Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 38. North America Allergen IgE Antibody Testing Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 39. Europe Allergen IgE Antibody Testing Growth Accelerators and Market Barriers
 Table 40. Europe Allergen IgE Antibody Testing Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Europe Allergen IgE Antibody Testing Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 42. Asia-Pacific Allergen IgE Antibody Testing Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 43. Asia-Pacific Allergen IgE Antibody Testing Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 44. Asia-Pacific Allergen IgE Antibody Testing Growth Accelerators and Market Barriers
 Table 45. Southeast Asia Allergen IgE Antibody Testing Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Central and South America Allergen IgE Antibody Testing Investment Opportunities and Key Challenges
 Table 47. Central and South America Allergen IgE Antibody Testing Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 48. Middle East and Africa Allergen IgE Antibody Testing Investment Opportunities and Key Challenges
 Table 49. Middle East and Africa Allergen IgE Antibody Testing Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 50. Oumeng Corporation Information
 Table 51. Oumeng Description and Major Businesses
 Table 52. Oumeng Product Models, Descriptions and Specifications
 Table 53. Oumeng Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 54. Oumeng Sales Value Proportion by Product in 2024
 Table 55. Oumeng Sales Value Proportion by Application in 2024
 Table 56. Oumeng Sales Value Proportion by Geographic Area in 2024
 Table 57. Oumeng Allergen IgE Antibody Testing SWOT Analysis
 Table 58. Oumeng Recent Developments
 Table 59. BioMerieux Corporation Information
 Table 60. BioMerieux Description and Major Businesses
 Table 61. BioMerieux Product Models, Descriptions and Specifications
 Table 62. BioMerieux Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 63. BioMerieux Sales Value Proportion by Product in 2024
 Table 64. BioMerieux Sales Value Proportion by Application in 2024
 Table 65. BioMerieux Sales Value Proportion by Geographic Area in 2024
 Table 66. BioMerieux Allergen IgE Antibody Testing SWOT Analysis
 Table 67. BioMerieux Recent Developments
 Table 68. Phadia Corporation Information
 Table 69. Phadia Description and Major Businesses
 Table 70. Phadia Product Models, Descriptions and Specifications
 Table 71. Phadia Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 72. Phadia Sales Value Proportion by Product in 2024
 Table 73. Phadia Sales Value Proportion by Application in 2024
 Table 74. Phadia Sales Value Proportion by Geographic Area in 2024
 Table 75. Phadia Allergen IgE Antibody Testing SWOT Analysis
 Table 76. Phadia Recent Developments
 Table 77. Mediwiss Corporation Information
 Table 78. Mediwiss Description and Major Businesses
 Table 79. Mediwiss Product Models, Descriptions and Specifications
 Table 80. Mediwiss Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 81. Mediwiss Sales Value Proportion by Product in 2024
 Table 82. Mediwiss Sales Value Proportion by Application in 2024
 Table 83. Mediwiss Sales Value Proportion by Geographic Area in 2024
 Table 84. Mediwiss Allergen IgE Antibody Testing SWOT Analysis
 Table 85. Mediwiss Recent Developments
 Table 86. Danaher Corporation Information
 Table 87. Danaher Description and Major Businesses
 Table 88. Danaher Product Models, Descriptions and Specifications
 Table 89. Danaher Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 90. Danaher Sales Value Proportion by Product in 2024
 Table 91. Danaher Sales Value Proportion by Application in 2024
 Table 92. Danaher Sales Value Proportion by Geographic Area in 2024
 Table 93. Danaher Allergen IgE Antibody Testing SWOT Analysis
 Table 94. Danaher Recent Developments
 Table 95. Omega Diagnostics Group Corporation Information
 Table 96. Omega Diagnostics Group Description and Major Businesses
 Table 97. Omega Diagnostics Group Product Models, Descriptions and Specifications
 Table 98. Omega Diagnostics Group Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 99. Omega Diagnostics Group Recent Developments
 Table 100. Biomerica Corporation Information
 Table 101. Biomerica Description and Major Businesses
 Table 102. Biomerica Product Models, Descriptions and Specifications
 Table 103. Biomerica Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 104. Biomerica Recent Developments
 Table 105. Stallergenes Greer Corporation Information
 Table 106. Stallergenes Greer Description and Major Businesses
 Table 107. Stallergenes Greer Product Models, Descriptions and Specifications
 Table 108. Stallergenes Greer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 109. Stallergenes Greer Recent Developments
 Table 110. Siemens Healthineers Corporation Information
 Table 111. Siemens Healthineers Description and Major Businesses
 Table 112. Siemens Healthineers Product Models, Descriptions and Specifications
 Table 113. Siemens Healthineers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 114. Siemens Healthineers Recent Developments
 Table 115. Quest Diagnostics Corporation Information
 Table 116. Quest Diagnostics Description and Major Businesses
 Table 117. Quest Diagnostics Product Models, Descriptions and Specifications
 Table 118. Quest Diagnostics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 119. Quest Diagnostics Recent Developments
 Table 120. Lincoln Diagnostics Corporation Information
 Table 121. Lincoln Diagnostics Description and Major Businesses
 Table 122. Lincoln Diagnostics Product Models, Descriptions and Specifications
 Table 123. Lincoln Diagnostics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 124. Lincoln Diagnostics Recent Developments
 Table 125. HOB Biotech Corporation Information
 Table 126. HOB Biotech Description and Major Businesses
 Table 127. HOB Biotech Product Models, Descriptions and Specifications
 Table 128. HOB Biotech Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 129. HOB Biotech Recent Developments
 Table 130. Beijing Macro Union Pharmaceutical Corporation Information
 Table 131. Beijing Macro Union Pharmaceutical Description and Major Businesses
 Table 132. Beijing Macro Union Pharmaceutical Product Models, Descriptions and Specifications
 Table 133. Beijing Macro Union Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 134. Beijing Macro Union Pharmaceutical Recent Developments
 Table 135. Hangzhou Zheda Dixun Biological Corporation Information
 Table 136. Hangzhou Zheda Dixun Biological Description and Major Businesses
 Table 137. Hangzhou Zheda Dixun Biological Product Models, Descriptions and Specifications
 Table 138. Hangzhou Zheda Dixun Biological Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 139. Hangzhou Zheda Dixun Biological Recent Developments
 Table 140. Key Raw Materials Distribution
 Table 141. Raw Materials Key Suppliers
 Table 142. Critical Raw Material Supplier Concentration (2024) & Risk Index
 Table 143. Milestones in Production Technology Evolution
 Table 144. Distributors List
 Table 145. Market Trends and Market Evolution
 Table 146. Market Drivers and Opportunities
 Table 147. Market Challenges, Risks, and Restraints
 Table 148. Research Programs/Design for This Report
 Table 149. Key Data Information from Secondary Sources
 Table 150. Key Data Information from Primary Sources


List of Figures
 Figure 1. Allergen IgE Antibody Testing Product Picture
 Figure 2. Global Allergen IgE Antibody Testing Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Skin Prick Testing Product Picture
 Figure 4. Serum-Specific IE Testing Product Picture
 Figure 5. Patch Testing Product Picture
 Figure 6. In Vitro Allergen Testing Product Picture
 Figure 7. Global Allergen IgE Antibody Testing Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 8. Aldult
 Figure 9. Child
 Figure 10. Allergen IgE Antibody Testing Report Years Considered
 Figure 11. Global Allergen IgE Antibody Testing Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Allergen IgE Antibody Testing Revenue (2020-2031) & (US$ Million)
 Figure 13. Global Allergen IgE Antibody Testing Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 14. Global Allergen IgE Antibody Testing Revenue Market Share by Region (2020-2031)
 Figure 15. Global Allergen IgE Antibody Testing Sales (2020-2031) & (K Units)
 Figure 16. Global Allergen IgE Antibody Testing Sales (CAGR) by Region (2020-2031) (K Units)
 Figure 17. Global Allergen IgE Antibody Testing Sales Market Share by Region (2020-2031)
 Figure 18. Top 5 and Top 10 Manufacturers Allergen IgE Antibody Testing Sales Volume Market Share in 2024
 Figure 19. Global Allergen IgE Antibody Testing Revenue Market Share Ranking (2024)
 Figure 20. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 21. Skin Prick Testing Revenue Market Share by Manufacturer in 2024
 Figure 22. Serum-Specific IE Testing Revenue Market Share by Manufacturer in 2024
 Figure 23. Patch Testing Revenue Market Share by Manufacturer in 2024
 Figure 24. In Vitro Allergen Testing Revenue Market Share by Manufacturer in 2024
 Figure 25. Global Allergen IgE Antibody Testing Sales Market Share by Type (2020-2031)
 Figure 26. Global Allergen IgE Antibody Testing Revenue Market Share by Type (2020-2031)
 Figure 27. Global Allergen IgE Antibody Testing Sales Market Share by Application (2020-2031)
 Figure 28. Global Allergen IgE Antibody Testing Revenue Market Share by Application (2020-2031)
 Figure 29. North America Allergen IgE Antibody Testing Sales YoY (2020-2031) & (K Units)
 Figure 30. North America Allergen IgE Antibody Testing Revenue YoY (2020-2031) & (US$ Million)
 Figure 31. North America Top 5 Manufacturers Allergen IgE Antibody Testing Sales Revenue (US$ Million) in 2024
 Figure 32. North America Allergen IgE Antibody Testing Sales Volume (K Units) by Type (2020- 2031)
 Figure 33. North America Allergen IgE Antibody Testing Sales Revenue (US$ Million) by Type (2020 - 2031)
 Figure 34. North America Allergen IgE Antibody Testing Sales Volume (K Units) by Application (2020-2031)
 Figure 35. North America Allergen IgE Antibody Testing Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 36. US Allergen IgE Antibody Testing Revenue (2020-2031) & (US$ Million)
 Figure 37. Canada Allergen IgE Antibody Testing Revenue (2020-2031) & (US$ Million)
 Figure 38. Mexico Allergen IgE Antibody Testing Revenue (2020-2031) & (US$ Million)
 Figure 39. Europe Allergen IgE Antibody Testing Sales YoY (2020-2031) & (K Units)
 Figure 40. Europe Allergen IgE Antibody Testing Revenue YoY (2020-2031) & (US$ Million)
 Figure 41. Europe Top 5 Manufacturers Allergen IgE Antibody Testing Sales Revenue (US$ Million) in 2024
 Figure 42. Europe Allergen IgE Antibody Testing Sales Volume (K Units) by Type (2020-2031)
 Figure 43. Europe Allergen IgE Antibody Testing Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 44. Europe Allergen IgE Antibody Testing Sales Volume (K Units) by Application (2020-2031)
 Figure 45. Europe Allergen IgE Antibody Testing Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 46. Germany Allergen IgE Antibody Testing Revenue (2020-2031) & (US$ Million)
 Figure 47. France Allergen IgE Antibody Testing Revenue (2020-2031) & (US$ Million)
 Figure 48. U.K. Allergen IgE Antibody Testing Revenue (2020-2031) & (US$ Million)
 Figure 49. Italy Allergen IgE Antibody Testing Revenue (2020-2031) & (US$ Million)
 Figure 50. Russia Allergen IgE Antibody Testing Revenue (2020-2031) & (US$ Million)
 Figure 51. Asia-Pacific Allergen IgE Antibody Testing Sales YoY (2020-2031) & (K Units)
 Figure 52. Asia-Pacific Allergen IgE Antibody Testing Revenue YoY (2020-2031) & (US$ Million)
 Figure 53. Asia-Pacific Top 8 Manufacturers Allergen IgE Antibody Testing Sales Revenue (US$ Million) in 2024
 Figure 54. Asia-Pacific Allergen IgE Antibody Testing Sales Volume (K Units) by Type (2020- 2031)
 Figure 55. Asia-Pacific Allergen IgE Antibody Testing Sales Revenue (US$ Million) by Type (2020- 2031)
 Figure 56. Asia-Pacific Allergen IgE Antibody Testing Sales Volume (K Units) by Application (2020-2031)
 Figure 57. Asia-Pacific Allergen IgE Antibody Testing Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 58. Indonesia Allergen IgE Antibody Testing Revenue (2020-2031) & (US$ Million)
 Figure 59. Japan Allergen IgE Antibody Testing Revenue (2020-2031) & (US$ Million)
 Figure 60. South Korea Allergen IgE Antibody Testing Revenue (2020-2031) & (US$ Million)
 Figure 61. China Taiwan Allergen IgE Antibody Testing Revenue (2020-2031) & (US$ Million)
 Figure 62. India Allergen IgE Antibody Testing Revenue (2020-2031) & (US$ Million)
 Figure 63. Central and South America Allergen IgE Antibody Testing Sales YoY (2020-2031) & (K Units)
 Figure 64. Central and South America Allergen IgE Antibody Testing Revenue YoY (2020-2031) & (US$ Million)
 Figure 65. Central and South America Top 5 Manufacturers Allergen IgE Antibody Testing Sales Revenue (US$ Million) in 2024
 Figure 66. Central and South America Allergen IgE Antibody Testing Sales Volume (K Units) by Type (2021-2031)
 Figure 67. Central and South America Allergen IgE Antibody Testing Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 68. Central and South America Allergen IgE Antibody Testing Sales Volume (K Units) by Application (2020-2031)
 Figure 69. Central and South America Allergen IgE Antibody Testing Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 70. Brazil Allergen IgE Antibody Testing Revenue (2020-2025) & (US$ Million)
 Figure 71. Argentina Allergen IgE Antibody Testing Revenue (2020-2025) & (US$ Million)
 Figure 72. Middle East, and Africa Allergen IgE Antibody Testing Sales YoY (2020-2031) & (K Units)
 Figure 73. Middle East and Africa Allergen IgE Antibody Testing Revenue YoY (2020-2031) & (US$ Million)
 Figure 74. Middle East and Africa Top 5 Manufacturers Allergen IgE Antibody Testing Sales Revenue (US$ Million) in 2024
 Figure 75. Middle East and Africa Allergen IgE Antibody Testing Sales Volume (K Units) by Type (2021-2031)
 Figure 76. South America Allergen IgE Antibody Testing Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 77. Middle East and Africa Allergen IgE Antibody Testing Sales Volume (K Units) by Application (2020-2031)
 Figure 78. Middle East and Africa Allergen IgE Antibody Testing Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 79. GCC Countries Allergen IgE Antibody Testing Revenue (2020-2025) & (US$ Million)
 Figure 80. Turkey Allergen IgE Antibody Testing Revenue (2020-2025) & (US$ Million)
 Figure 81. Egypt Allergen IgE Antibody Testing Revenue (2020-2025) & (US$ Million)
 Figure 82. South Africa Allergen IgE Antibody Testing Revenue (2020-2025) & (US$ Million)
 Figure 83. Allergen IgE Antibody Testing Industry Chain Mapping
 Figure 84. Regional Allergen IgE Antibody Testing Manufacturing Base Distribution (%)
 Figure 85. Global Allergen IgE Antibody Testing Production Market Share by Region (2020-2031)
 Figure 86. Allergen IgE Antibody Testing Production Process
 Figure 87. Regional Allergen IgE Antibody Testing Production Cost Structure
 Figure 88. Channels of Distribution (Direct Vs Distribution)
 Figure 89. Bottom-up and Top-down Approaches for This Report
 Figure 90. Data Triangulation
 Figure 91. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SIS Group of Schools